12:10 PM EST, 01/07/2025 (MT Newswires) -- CVS Health's ( CVS ) CVS Caremark unit has agreed to include Zydus Lifesciences' diabetes medications, Zituvio, Zituvimet, and Zituvimet XR in its template formulary, effective Jan. 1.

Approved by the US Food and Drug Administration through the 505(b)(2) pathway, the medications containing sitagliptin and metformin hydrochloride help improve glycemic control in adults with type 2 diabetes mellitus, Zydus Lifesciences said Tuesday.

Price: 45.96, Change: +0.13, Percent Change: +0.29